Status:
COMPLETED
To Study the Effects of Mango Ingestion in T2DM and Non-diabetic Subjects.
Lead Sponsor:
Diabetes Foundation, India
Collaborating Sponsors:
Indian Council of Medical Research
Conditions:
Normoglycemia
T2DM (Type 2 Diabetes Mellitus)
Eligibility:
All Genders
25-60 years
Phase:
NA
Brief Summary
T2DM patient will be recruited from endocrine OPD 1. Clinical History and Examination: 1. General Physical Examination: * Height (cm) * weight (kg) * BMI (kg/m2) * Blood ...
Detailed Description
1. Phase I: Exploratory Acute Phase- Stratified randomized study * Study population: 2 groups; patients with T2DM and non-diabetic subjects n=45 (20 T2DM subject, 25 non-diabetic subjects). * S...
Eligibility Criteria
Inclusion
- For patients with diabetes: Stable glycemic control on metformin or sulfonylurea for past 3 months and without any major complications and HbA1C less than 8%
Exclusion
- Acute infections and advanced end-organ damage
- History of hepatitis or pancreatitis, abnormal liver and renal functions
- Recent (\<3 months) changes in weight
- Any known allergy to mangoes and bread
- Subjects with hypothyroidism
- On any drug causing weight gain or weight loss.
Key Trial Info
Start Date :
February 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2023
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT06055582
Start Date
February 11 2022
End Date
March 1 2023
Last Update
September 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fortis CDOC Hospital
New Delhi, National Capital Territory of Delhi, India, 110048